Oncology is just 7% of sales, but GSK has bigger ambitions as industry pipelines set up fiercer competition for patients.
Travel brands' YouTube Shorts held viewers for 76.3% of the video on average in Q2 2026, up from just 17.0% a year earlier, according to a recent report from Dash Social.
Some 11% of working-age adults are uninsured, and nearly half lack adequate coverage, adding urgency to a key midterm issue for voters.
Marketers have more opportunities to educate female patients on how menstrual and menopausal changes are linked with heart health.
The ruling allows disputed efficacy claims to stay on air while their accuracy remains unresolved.
Walmart expands its digital healthcare marketplace with General Medicine, bringing personalized care shopping and new competition for online healthcare players.
Now in its fifth year, the program uses relatable role models to normalize active lifestyles for young patients with diabetes.
GLP-1 telehealth brands need transparent pricing and personalized ongoing support to keep patients from switching providers.
Consumers are spending on products that support their well-being, giving retailers opportunities beyond traditional health categories.
Multibrand direct-to-consumer pharma platforms help patients find affordable treatment options, giving drugmakers a chance to build credibility.
Marketers can encourage adoption of caregiving AI tools by emphasizing how practical use cases support loved ones' care without replacing human involvement.
TikTok’s peptide search restrictions could spur tighter oversight of promotions, affiliate deals, and seller links across social platforms.
Pharma’s deep pockets are driving AI platforms to bolster drug development despite limited evidence of the tech’s clinical and financial impact.
Health problems are a serious matter, but for people living with such conditions, humor can make difficult conversations easier to endure. For advertisers, finding that humor without trivializing someone's experience is a much harder assignment. At a panel during Advertising Week New York, executives and comedians discussed how brands can use humor when the subject is sensitive and the consequences of getting it wrong are significant.
Cosmetic, muscular, and emotional changes experienced by GLP-1 users often emerge within three months, making early telehealth and HCP guidance essential.
Doctors flock to OpenEvidence for clinical answers, giving drugmakers insights to deliver more relevant ads.
AI could cut clinical trial enrollment timelines and change how pharma spends on patient outreach.
This builds on its series of partnerships in China—a major hub for novel cancer drug development.
Oversaturated health influencer promotions and AI deepfakes are making verified expertise and credible voices essential for marketers.
Trump admin seeks faster access to wellness peptides, opening opportunities for consumer health brands despite lingering provider safety concerns.